Search - Inserm - Institut national de la santé et de la recherche médicale Access content directly

Filter your results

14 Results
authFullName_s : Gilles Romieu
Image document

High EGFR protein expression and exon 9 PIK3CA mutations are independent prognostic factors in triple negative breast cancers

William Jacot , Caroline Mollevi , Frédéric Fina , Evelyne El Lopez-Crapez , Pierre-Marie Martin , et al.
BMC Cancer, 2015, 15 (1), ⟨10.1186/s12885-015-1977-3⟩
Journal articles hal-02169644v1
Image document

Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers

Séverine Guiu , Caroline Mollevi , Céline Charon-Barra , Florence Boissière , Evelyne Crapez , et al.
British Journal of Cancer, 2018, 119 (1), pp.76-79. ⟨10.1038/s41416-018-0142-6⟩
Journal articles hal-02289193v1
Image document

Letrozole sensitizes breast cancer cells to ionizing radiation.

David Azria , Christel Larbouret , Severine Cunat , Mahmut Ozsahin , Sophie Gourgou , et al.
Breast Cancer Research, 2005, 7, pp.R156-63. ⟨10.1186/bcr969⟩
Journal articles inserm-00094862v1
Image document

Changes in vitamin D and calcium metabolism markers in patients undergoing adjuvant chemotherapy for breast cancer

Marie Viala , Nelly Firmin , Célia Touraine , Stéphane Pouderoux , Manon Metge , et al.
BMC Cancer, 2021, 21 (1), pp.815. ⟨10.1186/s12885-021-08563-4⟩
Journal articles inserm-03292972v1
Image document

Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes

Elsa Curtit , Xavier Pivot , Julie Henriques , Sophie Paget-Bailly , Pierre Fumoleau , et al.
Breast Cancer Research, 2016, 19 (1), pp.98. ⟨10.1186/s13058-017-0888-4⟩
Journal articles inserm-01577637v1
Image document

Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis

Celine Lefebvre , Thomas Bachelot , Thomas Filleron , Marion Pedrero , Mario Campone , et al.
PLoS Medicine, 2016, 13 (12), pp.e1002201. ⟨10.1371/journal.pmed.1002201⟩
Journal articles hal-02297451v1
Image document

uPA/PAI-1, Oncotype DX™, MammaPrint®. Valeurs pronostique et prédictive pour une utilité clinique dans la prise en charge du cancer du sein

Elisabeth Luporsi , Jean-Pierre Bellocq , Jérôme Barrière , Julia Bonastre , Jérôme Chetritt , et al.
Bulletin du Cancer, 2015, 102 (9), pp.719-729. ⟨10.1016/j.bulcan.2015.05.003⟩
Journal articles inserm-02328397v1

uPA/PAI-1, Oncotype DX™, Mammaprint®. Valeurs pronostique et prédictive pour une utilité clinique dans la prise en charge du cancer du sein

Jean-Pierre Bellocq , Elisabeth Luporsi , Jérôme Barrière , Julia Bonastre , Jérôme Chetritt , et al.
Annales de Pathologie, 2014, 34 (5), pp.349-351. ⟨10.1016/j.annpat.2014.04.010⟩
Journal articles inserm-02328249v1
Image document

A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers

Anthony Ferrari , Anne Vincent-Salomon , Xavier Pivot , Anne-Sophie Sertier , Emile Thomas , et al.
Nature Communications, 2016, 7, pp.Article number: 12222. ⟨10.1038/ncomms12222⟩
Journal articles hal-01388446v1

Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer.

Stephen Johnston , John Pippen , Xavier B. Pivot , Mikhail Lichinitser , Saeed Sadeghi , et al.
Journal of Clinical Oncology, 2009, 27 (33), pp.5538-46. ⟨10.1200/JCO.2009.23.3734⟩
Journal articles inserm-00484768v1
Image document

Short- and long-term impact of adapted physical activity and diet counseling during adjuvant breast cancer therapy: the “APAD1” randomized controlled trial

Marion Carayol , Gregory Ninot , Pierre Senesse , Jean-Pierre Bleuse , Sophie Gourgou , et al.
BMC Cancer, 2019, 19 (1), pp.737. ⟨10.1186/s12885-019-5896-6⟩
Journal articles inserm-02297744v1
Image document

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Xavier Pivot , Gilles Romieu , Marc Debled , Jean-Yves Pierga , Pierre Kerbrat , et al.
The Lancet, 2019, 393 (10191), pp.2591-2598
Journal articles inserm-02944688v1

Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer.

David W. Miles , Arlene Chan , Luc Y. Dirix , Javier Cortés , Xavier B. Pivot , et al.
Journal of Clinical Oncology, 2010, 28 (20), pp.3239-47. ⟨10.1200/JCO.2008.21.6457⟩
Journal articles inserm-00508083v1
Image document

Landscape of somatic mutations in 560 breast cancer whole-genome sequences

Serena Nik-Zainal , Helen R. Davies , Johan Staaf , Manasa Ramakrishna , Dominik Glodzik , et al.
Nature, 2016, 534 (7605), pp.47 - 54. ⟨10.1038/nature17676⟩
Journal articles hal-01388447v1